Benzinga | Oct 5, 2020 09:12AM EDT

Ladenburg Thalmann Downgrades Benitec Biopharma to Neutral

Ladenburg Thalmann analyst Robert LeBoyer downgrades Benitec Biopharma (NASDAQ:BNTC) from Buy to Neutral.